RT in combination with the anti‐PD‐L1 also significantly reduced infiltration of CD4+CD25+FOXP3+ T regulatory cells (Byrne et al, 2011), further supporting the notion that PD‐L1 checkpoint inhibition together with RT can counteract the immunosuppressive tumor environment. Here, CD4 is linked to neoplasm.